Bionanoplus

Project ID:

862444

Title:

Anticipating Safety Issues at the Design Stage of NAno Product Development

Funded under:

This project has received funding from the European Union’s Horizon 2020 research and innovation programme

Project details:

Total cost: EUR 6,052,761.06
EU contribution: EUR 5,998,386.06
Coordinated in: Italy
Topic(s): NMBP-15-2019 Safe by design, from science to regulation: metrics and main sectors
Call for proposal: H2020-NMBP-TO-IND-2018-2020
Funding scheme: RIA – Research and Innovation action

Objective:

ASINA aims to:

• Support the fast industrial uptake of nanotechnology by providing Safe-by-Design solutions and supporting tools
• Provide entrepreneurs knowledge and awareness of Safe-by-Design potential
• Increase confidence in Safe-by-Design nanomanufacturing by improving the interaction and integration of different stakeholders (entrepreneurs, scientists, regulators, innovators, policy makers).

Coordinator:

CNR – Consiglio Nazionale Delle Ricerche
Italy

Participants:

• Consiglio Nazionale delle Ricerche
• University Milano-Bicocca
• Fundación Tecnalia Research & Innovation
• Acondicionamiento Tarrasense (LEITAT)
• Centre for Nanotechnology and Smart Materials (CENTI)
• Transgero Ltd
• University of Limerick
• Commissariat à l’énergie atomique et aux énergies alternatives (CEA)
• UK Centre for Ecology & Hydrology
• Project Hub 360
• Ente Italiano di Normazione (UNI)
• Colorobbia Consulting Srl
• WIVA Group Spa
• Mica Nanotech Ltd
• Bionanoplus SL
• Red of View SRL
• Air Pollution Management
• Warrant Hub Spa
• Angel Consulting SAS
• Iowa State University
• People for the Ethical Treatment of Animals (PETA)
• Witek Srl

Web site:

asina.project.eu

Project title:

Sistemas poliméricos innovadores needle-free para la potenciación de la respuesta inmune

Reference number:

IDI-20210277

Partners:

• Bionanoplus S.L.
• Asociación de la Industria Navarra (AIN)

Funding Agency:

«Cervera center of excellence» – Technology transfer project

“Funded by CDTI”

Objective:

Development and application of polymeric systems acting as adjuvants for needle-free administration of vaccines against alergic asthma

Duration:

June 2020 – May 2024

Project title:

Biotecnología aplicada a la obtención de polímeros imprimibles para aplicaciones biomédicas a  partir de subproductos de origen agroalimentario de Navarra

Reference number:

0011-1411-2021-000049

Partners:

• Asociación de la Industria Navarra (AIN)
• Bionanoplus S.L.
• Fundación CENER CIEMAT
• Ingredalia S.L.
• Cocuus System Iberica S.L.
• Tratamiento Subproductos Agroalimentarios (TRASA)
• Universidad de Navarra

Funding Agency:

This project is part of the Regional Research and Innovation Strategies for Smart Specialization (S3)

Objective:

Revalorization of organic subproducts from the agro-food industry in order to develop nanoencapsulated antimicrobial compounds.

Development of new polymeric support systems for their application in regenerative medicine through 3D printing, more specifically production and testing of human cardiac tissue.

Duration:

2021-2023

Project title:

 Breast Long non coding ANti-Cancer Antigens: Utilización de datos genómicos para generar una vacuna contra el cáncer

Reference number:

0011-1411-2021-000044

Partners:

• Fundación para la Investigación Médica Aplicada (FIMA)
• Bionanoplus S.L.
• Fundación ADITECH
• Fundación Pública Miguel Servet (Navarrabiomed)
• Universidad de Navarra
• Asociación Saray

Funding Agency:

This project is part of the Regional Research and Innovation Strategies for Smart Specialization (S3)

Objective:

Development of a novel RNA vaccine against triple-negative breast cancer (TNBC) and hepatocarcinoma (HCC)

Duration:

2021-2023

Project title:

Creación de una plataforma para el desarrollo de vectores de terapia génica con tropismo renal

Reference number:

0011-1411-2019-000015

Partners:

• Bionanoplus S.L.
• Asociación de la Industria Navarra (AIN)
• Fundación para la investigación médica aplicada (FIMA)
• Clínica Universidad de Navarra
• Fundación ADITECH

Funding Agency:

This project is part of the Regional Research and Innovation Strategies for Smart Specialization (S3), and more specifically within the personalized medicine strategic priority of the Government of Navarre.

Objective:

Development of a novel combination of gene therapy and nanotechnology in order to address kidney disease

Duration:

2019-2021

Project title:

Use of mucoadhesive polymeric formulations for the eradication of Helicobacter pylori

Reference number:

RTC-2017-6643-1

Partners:

• Bionanoplus SL
• Laboratorio Reig Jofre SA
• Clínica Universidad de Navarra
• Universidad de Sevilla

Funding Agency:

Ministry of Economy and Competitiveness, within the State Program of Research, Development and Innovation Oriented to the Challenges of Society  under the State Plan of Scientific and Technical Research, and Innovation 2017-2020.

Objective:

Development of a controlled drug release treatment for gastric ulcers caused by H. pylori using an innovative mucoadhesive polymeric formulation.

A longer residence time of the active principles in the mucous membrane of the stomach, combining local and systemic action will allow addressing this important therapeutic challenge with a disruptive treatment approach .

Duration:

2018-2021

Project title:

Valorization of new vaccines against respiratory tract pathogens for the reduction of antibiotic use in swine

Reference number:

RTC-2017-6601-2

Partners:

• Bionanoplus SL
• Vaxdyn SL
• ADL Bionatur Solutions SA
• Instituto de Parasitología y Biomedicina López Neyra (IPBLN)
• Universidad de Córdoba

Funding Agency:

Ministry of Economy and Competitiveness, within the State Program of Research, Development and Innovation Oriented to the Challenges of Society  under the State Plan of Scientific and Technical Research, and Innovation 2017-2020.

Objective:

Development of genetically engineered modified vaccines against respiratory diseases in swine

Duration:

2018-2019

Project title:

3DBioPrint: Impresión 3D de biomateriales basados en polímeros naturales para aplicaciones en tejido protésico y liberación controlada transdérmica

Reference number:

0011-1365-2018-000250

Partners:

• Bionanoplus SL
• AIN (Asociación de la Industria Navarra)

Funding Agency:

This project is part of the Regional Research and Innovation Strategies for Smart Specialization (S3), and more specifically within the advanced manufacturing strategic priority of the Government of Navarre.

Objective:

Development of biocompatible and biodegradable materials, transdermal delivery systems as well as hard tissue prosthethic devices by means of 3D printing zein-based thermoplastic filaments.

Duration:

2018-2019

Project title:

AgroPestAlert: Internet de las Cosas para la detección en tiempo real de insectos-plagas en la agricultura

Reference number:

0011-1365-2017-000193

Partners:

• Bionanoplus SL
• Tecnologías y Servicios TiempoReal SL

Funding Agency:

This project is part of the Regional Research and Innovation Strategies for Smart Specialization (S3), and more specifically within the alimentary supply chain strategic priority of the Government of Navarre.

Objective:

Development of a complete  pest control management system based on an interconnected network of intelligent electronic devices, or traps, supported by a cloud based data analysis application.  The integration of both will allow for the identification of pests and their control and contention.

Duration:

2017-2019

Project reference:

728455

Funded under:

H2020

“SAP-Nano, Self-Assembled Polymeric Nanoparticulate systems”

Objective:

This project (SAP-Nano) is based on the application of a patented technology, versatile and easy to scale up in order to encapsulate antigens and develop new veterinary vaccines.

Coordinator:

Bionanoplus S.L.

Web site:

https://ec.europa.eu/easme/en/sme/8351/disruptive-technology-vaccines-manufacturing-based-self-assembled-polymeric-nanoparticulate

Project reference:

685909

Funded under:

H2020-EU.2.1.2., H2020-EU.2.1.2.2., H2020-EU.2.1.2.3., H2020- EU.2.1.2.5.

SKin Healthcare by Innovative NanoCAPsuleS
From 2015-10-01 to 2019-09-30, ongoing project

Project details:

Total cost: EUR 3 265 920,75
EU contribution: EUR 3 265 920,75
Coordinated in: Portugal
Topic(s): NMP-06-2015 – Novel nanomatrices and nanocapsules
Call for proposal: H2020-NMP-PILOTS-2015
Funding scheme: RIA – Research and Innovation action

Objective:

SKHINCAPS project will explore an innovative and sustainable in situ self-assembly nanoencapsulation technology to deliver novel products for skin healthcare applications, with increased efficiency and cost benefits, leading to ground-breaking innovations on the actual products. Using this safe, sustainable and easily scalable technology, different actives will be addressed for nanoencapsulation: phase-change materials (PCMs), a cocktail of vitamins and antioxidants, and natural essential oils…

Coordinator:

CENTITVC – CENTRO DE NANOTECNOLOGIA E MATERIAIS TECNICOS FUNCIONAIS E INTELIGENTES ASSOCIACAO
Portugal

Participants:

• BIONANOPLUS SL Spain
• ASOCIACION INDUSTRIAL DE OPTICA, COLOR E IMAGEN Spain
• UNIVERSITAT POLITECNICA DE CATALUNYA Spain
• INSTITUT FUER VERBUNDWERKSTOFFE GMBH Germany
• DEVAN-MICROPOLIS S.A.Portugal
• TELIC SAUSpain
• PRO-ACTIVEBelgium
• Teknologian tutkimuskeskus VTT yo Finland

Web site:

skhincaps.eu

Project title:

DEVELOPMENT OF INNOVATIVE FORMULATIONS OF MUCOADHESIVE NANOPARTICLES FOR THE TREATMENT OF MUCOSAL ULCERS (NANOMUC)

Reference number:

RTC-2015-4437-1

Partners:

• Bionanoplus SL
• Laboratorio Reig Jofre SA
• Universidad de Navarra
• Universidad de Sevilla

Funding Agency:

Ministry of Economy and Competitiveness, within the State Program of Research, Development and Innovation Oriented to the Challenges of Society  under the State Plan of Scientific and Technical Research, and Innovation 2013-2016.

Objective:

Development of controlled drug release treatments using innovative formulations of mucoadhesive polymeric nanoparticles. This will allow a longer residence of active principles in the mucous, combining local and systemic action, and resulting in a more effective treatment.

Duration:

2015-2017

Project title:

INNOVATIVE TECHNOLOGIES FOR THE DEVELOPMENT OF HEALTHY NEW POLYPHENOL-BASED PRODUCTS (INNOFENOL)
TECNOLOGÍAS INNOVADORAS PARA EL DESARROLLO DE NUEVOS PRODUCTOS SALUDABLES A BASE DE POLIFENOLES (INNOFENOL)

Partners:

• Bionanoplus SL
• Natac SL
• Quantum Experimental SL
• Elaborados Dietéticos SA
• Centro Nacional de Biotecnología del CSIC
• Instituto de Química Médica del CSIC
• Universidad Complutense de Madrid

Funding Agency:

Ministry of Economy and Competitiveness. 2012-2015.